A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Hepatocellular Carcinoma · Metastatic Hepatocellular Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Clinical Trial Site, Phoenix, Arizona, United States

  • Clinical Trial Site, La Jolla, California, United States

  • Clinical Trial Site, Los Angeles, California, United States

  • Clinical Trial Site, Jacksonville, Florida, United States

  • Clinical Trial Site, Atlanta, Georgia, United States

  • Clinical Trial Site, Chicago, Illinois, United States

  • Clinical Trial Site, Ann Arbor, Michigan, United States

  • Clinical Trial Site, Rochester, Minnesota, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, New York, New York, United States

  • Clinical Trial Site, Cleveland, Ohio, United States

  • Clinical Trial Site, Pittsburgh, Pennsylvania, United States

  • Clinical Trial Site, Dallas, Texas, United States

  • Clinical Trial Site, Houston, Texas, United States

  • Clinical Trial Site, San Antonio, Texas, United States

  • Clinical Trial Site, Richmond, Virginia, United States

  • Clinical Trial Site, Milan, Italy

  • Clinical Trial Site, Rozzano, Italy

  • Clinical Trial Site, Verona, Italy

  • Clinical Trial Site, Busan, South Korea

  • Clinical Trial Site, Seongnam, South Korea

  • Clinical Trial Site, Seongnam, South Korea

  • Clinical Trial Site, Seoul, South Korea

מובילי המחקר
  • Medical Director

    Study Director

    Alnylam Pharmaceuticals